Skip to main content
  • 1126 Accesses

Abstract

Obesity is a health epidemic problem and a major contributor to the increased occurrence of coronary heart disease, hypertension, and type 2 diabetes. The obesity trend is dramatically increasing in Western societies as well as in developing countries, representing a problem also for women in gestational age. Obesity in pregnancy is a direct consequence of the global obesity epidemic increase. Obesity is associated with a metabolic environment characterized by inflammation, insulin resistance, hyperlipidemia, and vascular dysfunction. Excess of fat mass, particularly visceral and ectopic fat, is viewed as the primary driver of this inflammation. In obese pregnant women, the feto-placental unit develops under conditions of inflammation and excess of nutrients, with serious implications for morbidity and mortality both for the mother and the baby. During pregnancy, maternal obesity and excessive gestational weight gain have been associated with increased risk for maternal pathologies and detrimental long-term effects on fetal tissues, compromising fetal programming and its future health.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Gallus S, Lugo A, Murisic B, Bosetti C, Boffetta P, La Vecchia C. Overweight and obesity in 16 European countries. Eur J Nutr. 2014. doi:10.1007/s00394-014-0746-4 [Epub a head of print]

  2. Janssen I, Katzmarzyk PT, Ross R. Body mass index, waist circumference, and health risk: evidence in support of current National Institutes of Health guidelines. Arch Intern Med. 2002;162(18):2074–9.

    Article  PubMed  Google Scholar 

  3. Kelly T, Yang W, Chen CS, Reynolds K, He J. Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond). 2008;32(9):1431–7.

    Article  CAS  Google Scholar 

  4. Webber L, Divajeva D, Marsh T, McPherson K, Brown M, Galea G, Breda J. The future burden of obesity-related diseases in the 53 WHO European-Region countries and the impact of effective interventions: a modelling study. BMJ Open. 2014;4(7). doi:10.1136/bmjopen-2014-004787 [Epub a head of print]

  5. WHO, Global Database on Body Mass Index, World Health Organization. 2011. Available at: www.who.int/topics/obesity/en/

  6. WHO. Waist circumference and waist–hip ratio: report of a WHO expert consultation. 2008; WHO Document Production Services, Geneva, Switzerland;p.1–39.

    Google Scholar 

  7. Onat A, Avci GS, Barlan MM, Uyarel H, Uzunlar B, Sansoy V. Measures of abdominal obesity assessed for visceral adiposity and relation to coronary risk. Int J Obes Relat Metab Disord. 2004;28(8):1018–25.

    Article  CAS  PubMed  Google Scholar 

  8. Bastien M, Poirier P, Lemieux I, Després JP. Overview of epidemiology and contribution of obesity to cardiovascular disease. Prog Cardiovasc Dis. 2014;56(4):369–81.

    Article  PubMed  Google Scholar 

  9. Burgio E, Lopomo A, Migliore L. Obesity and diabetes: from genetics to epigenetics. Mol Biol Rep. 2015;42(4):799–818. doi:10.1007/s11033-014-3751-z.

  10. Loos RJ. Genetic determinants of common obesity and their value in prediction. Best Pract Res Clin Endocrinol Metab. 2012;26(2):211–26.

    Google Scholar 

  11. Loos RJ, Bouchard C. Obesity – is it a genetic disorder? J Intern Med. 2003;254(5):401–25.

    Article  CAS  PubMed  Google Scholar 

  12. Slomko H, Heo HJ, Einstein FH. Minireview: epigenetics of obesity and diabetes in humans. Endocrinology. 2012;153(3):1025–30.

    Google Scholar 

  13. Cancello R, Clément K. Is obesity an inflammatory illness? Role of low-grade inflammation and macrophage infiltration in human white adipose tissue. BJOG. 2006;113(10):1141–7.

    Article  CAS  PubMed  Google Scholar 

  14. Cancello R, Tordjman J, et al. Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. Diabetes. 2006;55(6):1554–61.

    Article  CAS  PubMed  Google Scholar 

  15. Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annu Rev Immunol. 2011;29:415–45. doi:10.1146/annurev-immunol-031210-101322.

  16. Heilbronn LK, Campbell LV, et al. Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity. Curr Pharm Des. 2008;14(12):1225–30.

    Article  CAS  PubMed  Google Scholar 

  17. Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444(7121):860–7.

    Article  CAS  PubMed  Google Scholar 

  18. Hotamisligil GS. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell. 2010;140(6):900–17.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  19. Cancello R, Tounian A, et al. Adiposity signals, genetic and body weight regulation in humans. Diabetes Metab. 2004;30(3):215–27.

    Article  CAS  PubMed  Google Scholar 

  20. Ouchi N, Parker JL, et al. Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2011;11(2):85–97.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  21. Tritos NA, Mantzoros CS. Leptin: its role in obesity and beyond. Diabetologia. 1997;14(12):1371–9.

    Article  Google Scholar 

  22. Fantuzzi G, Faggioni R, et al. Leptin in the regulation of immunity, inflammation and hematopoiesis. J Leukoc. 2000;68:437–46.

    CAS  Google Scholar 

  23. Cancello R, Henegar C, et al. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes. 2005;54(8):2277–86.

    Article  CAS  PubMed  Google Scholar 

  24. Jo J, Gavrilova O, et al. Hypertrophy and/or hyperplasia: dynamics of adipose tissue growth. PLoS Comput Biol. 2009;5:e1000324.

    Article  PubMed Central  PubMed  Google Scholar 

  25. Bouloumié A, Casteilla L, et al. Adipose tissue lymphocytes and macrophages in obesity and insulin resistance: makers or markers, and which comes first? Arterioscler Thromb Vasc Biol. 2008;28(7):1211–3.

    Article  PubMed  Google Scholar 

  26. Hammar EB, Irminger JC, Rickenbach K, Parnaud G, Ribaux P, Bosco D, et al. Activation of NF-kappaB by extracellular matrix is involved in spreading and glucose-stimulated insulin secretion of pancreatic beta cells. J Biol Chem. 2005;26(34):30630–7.

    Article  Google Scholar 

  27. Aviram A, Hod M. Maternal obesity: implications for pregnancy outcome and long-term risks-a link to maternal nutrition. Int J Gynaecol Obstet. 2011;115(1):S6–10.

    Article  PubMed  Google Scholar 

  28. Norman JE, Reynolds RM. The consequences of obesity and excess weight gain in pregnancy. Proc Nutr Soc. 2011;70(4):514.

    Article  Google Scholar 

  29. Papachatzi E, Dimitriou G. Pre-pregnancy obesity: maternal, neonatal and childhood outcomes. J Neonatal Perinatal Med. 2013;6(3):203–16.

    CAS  PubMed  Google Scholar 

  30. Sattar N, Greer IA. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? BMJ. 2002;325(7356):157–60.

    Article  PubMed Central  PubMed  Google Scholar 

  31. Taylor PD, Samuelsson AM. Maternal obesity and the developmental programming of hypertension: a role for leptin. Acta Physiol. 2010;3:508–23.

    Google Scholar 

  32. Tenenbaum-Gavish K, Hod M. Impact of maternal obesity on fetal health. Fetal Diagn Ther. 2013;34(1):1–7.

    Article  PubMed  Google Scholar 

  33. Aune D, Saugstad OD. Maternal body mass index and the risk of fetal death, stillbirth, and infant death: a systematic review and meta-analysis. JAMA. 2014;311(15):1536–46.

    Article  CAS  PubMed  Google Scholar 

  34. Frias AE, Grove KL. Obesity: a transgenerational problem linked to nutrition during pregnancy. Semin Reprod Med. 2012;30(6):472–8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  35. Bashiri A, Heo HJ. Pregnancy complicated by obesity induces global transcript expression alterations in visceral and subcutaneous fat. Mol Genet Genomics. 2014;289:695–705.

    Article  CAS  PubMed  Google Scholar 

  36. Denison FC, Roberts KA. Obesity, pregnancy, inflammation, and vascular function. Reproduction. 2010;140(3):373–85.

    Article  CAS  PubMed  Google Scholar 

  37. Lindqvist P, Dahlback B. Thrombotic risk during pregnancy: a population study. Obstet Gynecol. 1999;94(4):595–9.

    Article  CAS  PubMed  Google Scholar 

  38. Molyneaux E, Poston L. Obesity and mental disorders during pregnancy and postpartum: a systematic review and meta-analysis. Obstet Gynecol. 2014;123(4):857–67.

    Article  PubMed Central  PubMed  Google Scholar 

  39. Roberts KA, Riley SC. Placental structure and inflammation in pregnancies associated with obesity. Placenta. 2011;32(3):247–54.

    Article  CAS  PubMed  Google Scholar 

  40. Westermeier F, Sáez PJ. Programming of fetal insulin resistance in pregnancies with maternal obesity by ER stress and inflammation. Biomed Res Int. 2014;2014:917672. doi:10.1155/2014/917672. [Epub 2014 Jun 30].

  41. Xu J, Zhao YH. Maternal circulating concentrations of tumor necrosis factor-alpha, leptin, and adiponectin in gestational diabetes mellitus: a systematic review and meta-analysis. Scientific World J. 2014;2014:926932. doi:10.1155/2014/926932 [Epub 2014 Aug 19].

  42. Jeyabalan A. Epidemiology of preeclampsia: impact of obesity. Nutr Rev. 2013;71 Suppl 1:S18–25.

    Article  PubMed  Google Scholar 

  43. Jones CJ, Hartmann M. Ultrastructural localization of insulin receptors in human placenta. Am J Reprod Immunol. 1993;30(2-3):136–45.

    Article  CAS  PubMed  Google Scholar 

  44. Desoye G, Hartmann M. Location of insulin receptors in the placenta and its progenitor tissues. Microsc Res Tech. 1997;38(1–2):36–75.

    Google Scholar 

  45. Kirwan JP, Hauguel-de Mouzon S. TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes. 2002;51(7):2207–13.

    Article  CAS  PubMed  Google Scholar 

  46. Radaelli T, Varastehpour A. Gestational diabetes induces placental genes for chronic stress and inflammatory pathways. Diabetes. 2003;52(12):2951–8.

    Article  CAS  PubMed  Google Scholar 

  47. Köşüş N, Köşüş A. Relation between abdominal subcutaneous fat tissue thickness and inflammatory markers during pregnancy. Arch Med Sci. 2014;10(4):739–45.

    PubMed Central  PubMed  Google Scholar 

  48. Straughen JK, Trudeau S. Changes in adipose tissue distribution during pregnancy in overweight and obese compared with normal weight women. Nutr Diabetes. 2013;3:e84. doi:10.1038/nutd.2013.25.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  49. Tessier DR, Ferraro ZM. Role of leptin in pregnancy: consequences of maternal obesity. Placenta. 2013;34(3):205–11.

    Article  CAS  PubMed  Google Scholar 

  50. Hauguel-de Mouzon S. The known and unknown of leptin in pregnancy. Am J Obstet Gynecol. 2006;194(6):1537–45.

    Article  CAS  PubMed  Google Scholar 

  51. Masuzaki H, Ogawa Y. Non-adipose tissue production of leptin: leptin as a novel placenta-derived hormone in humans. Nat Med. 1997;3(9):1029–113.

    Article  CAS  PubMed  Google Scholar 

  52. Highman T, Friedman J. Longitudinal changes in maternal leptin serum concentrations, body composition and resting metabolic rate in pregnancy. Am J Obstet Gynecol. 1998;178(5):1010–5.

    Article  CAS  PubMed  Google Scholar 

  53. Poston L. Leptin and preeclampsia. Semin Reprod Med. 2002;20(2):131–8.

    Article  CAS  PubMed  Google Scholar 

  54. Aye IL, Powell TL. Adiponectin-the missing link between maternal adiposity, placental transport and fetal growth? Placenta. 2013;34(Suppl):S40–5.

    Article  CAS  PubMed  Google Scholar 

  55. Briana DD, Malamitsi-Puchner A. Adipocytokines in normal and complicated pregnancies. Reprod Sci. 2009;16(10):921–37.

    Article  CAS  PubMed  Google Scholar 

  56. Mazaki-Tovi S, Kanety H. Maternal serum adiponectin levels during human pregnancy. J Perinatol. 2007;27(2):77–81.

    Article  CAS  PubMed  Google Scholar 

  57. Corbetta S, Bulfamante G. Adiponectin expression in human fetal tissues during mid- and late gestation. J Clin Endocrinol Metab. 2005;90(4):2397–402.

    Article  CAS  PubMed  Google Scholar 

  58. Haghiac M, Basu S. Patterns of adiponectin expression in term pregnancy: impact of obesity. J Clin Endocrinol Metab. 2014;99(9):3427–34.

    Article  CAS  PubMed  Google Scholar 

  59. Challier JC. Obesity in pregnancy stimulates macrophage accumulation and inflammation in the placenta. Placenta. 2008;29(3):274–81. doi:10.1016/j.placenta.2007.12.010.

  60. Basu S, Leahy P. Molecular phenotype of monocytes at the maternal-fetal interface. Am J Obstet Gynecol. 2011;205(3):265.e1–8. doi:http://dx.doi.org/10.1016/j.ajog.2011.06.037.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Raffaella Cancello .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Cancello, R. (2015). Obesity and Inflammation in Pregnancy. In: Ferrazzi, E., Sears, B. (eds) Metabolic Syndrome and Complications of Pregnancy. Springer, Cham. https://doi.org/10.1007/978-3-319-16853-1_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-16853-1_5

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-16852-4

  • Online ISBN: 978-3-319-16853-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics